Literature DB >> 24619853

Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.

Keiichi Okano1, Minoru Oshima, Shinichi Yachida, Yoshio Kushida, Kiyohito Kato, Hideki Kamada, Masaki Wato, Tomohiko Nishihira, Yo Fukuda, Takashi Maeba, Hideyuki Inoue, Tsutomu Masaki, Yasuyuki Suzuki.   

Abstract

BACKGROUND: Carcinoma of the ampulla of Vater is uncommon. This study aimed to clarify predictors of survival for ampullary adenocarcinoma and to identify characteristics of its two major pathological subtypes.
METHODS: Medical records were reviewed for 86 patients who underwent curative resection for ampullary adenocarcinoma between 2000 and 2012 at 12 principal hospitals in Kagawa, Japan.
RESULTS: Resection was most common among 75-79-year-old patients. Actuarial 1-, 3-, and 5-year postoperative survival rates for ampullary adenocarcinoma were 90%, 72.3%, and 69.1%, respectively. Preoperative biliary drainage; serum CA19-9 and total bilirubin levels; pathological grade; perineural, vascular, pancreatic, and duodenal invasion; nodal metastasis; UICC-T stage; and pancreatobiliary subtype were predictors of poor survival. An elevated serum CA19-9 level; an elevated total bilirubin level; lymphatic, vascular, perineural, and pancreatic invasion; and advanced overall tumor stage were more common in patients with pancreatobiliary-type tumors than in patients with intestinal-type tumors. Additionally, pathologic subtype analysis showed that each subtype had distinct prognostic factors.
CONCLUSIONS: Preoperative elevated serum CA19-9 and total bilirubin levels are prognostic factors for ampullary adenocarcinoma, and are both associated with pancreatobiliary-type tumors. Surgeons should be aware of these factors because pancreatobiliary-type adenocarcinoma is aggressively invasive and is associated with poor survival.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CA19-9; ampullary adenocarcinoma; intestinal-type; pancreatobiliary type; predictive factor

Mesh:

Substances:

Year:  2014        PMID: 24619853     DOI: 10.1002/jso.23600

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Metastatic Signet Ring Cell Carcinoma of the Ampulla of Vater with an Unusually Prolonged Survival.

Authors:  Chandana Javvaji; Jacob R Bledsoe; Lloyd Hutchinson; Ediz F Cosar; Lacey J McIntosh; Venu G Bathini
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.

Authors:  Michelle D Reid; Serdar Balci; Nobuyuki Ohike; Yue Xue; Grace E Kim; Takuma Tajiri; Bahar Memis; Ipek Coban; Anil Dolgun; Alyssa M Krasinskas; Olca Basturk; David A Kooby; Juan M Sarmiento; Shishir K Maithel; Bassel F El-Rayes; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

Review 3.  [Papillary tumors - therapeutic concepts].

Authors:  F C Popp; J Weigt; T Kalinski; C Betzler; J Arend; B Garlipp; C Benckert; C J Bruns
Journal:  Chirurg       Date:  2015-08       Impact factor: 0.955

4.  Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

Authors:  Shinichi Yachida; Laura D Wood; Masami Suzuki; Erina Takai; Yasushi Totoki; Mamoru Kato; Claudio Luchini; Yasuhito Arai; Hiromi Nakamura; Natsuko Hama; Asmaa Elzawahry; Fumie Hosoda; Tomoki Shirota; Nobuhiko Morimoto; Kunio Hori; Jun Funazaki; Hikaru Tanaka; Chigusa Morizane; Takuji Okusaka; Satoshi Nara; Kazuaki Shimada; Nobuyoshi Hiraoka; Hirokazu Taniguchi; Ryota Higuchi; Minoru Oshima; Keiichi Okano; Seiko Hirono; Masamichi Mizuma; Koji Arihiro; Masakazu Yamamoto; Michiaki Unno; Hiroki Yamaue; Matthew J Weiss; Christopher L Wolfgang; Toru Furukawa; Hitoshi Nakagama; Bert Vogelstein; Tohru Kiyono; Ralph H Hruban; Tatsuhiro Shibata
Journal:  Cancer Cell       Date:  2016-01-21       Impact factor: 31.743

5.  Influence of non-jaundice stage at diagnosis on clinicopathological features and long-term survival of patients with periampullary carcinomas.

Authors:  Xiaoqian Peng; Xiaoxiao Jiao; Ping Zhao; Rongtao Zhu; Yuling Sun; Lin Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 6.  Ampullary carcinoma of the duodenum: current clinical issues and genomic overview.

Authors:  Keiichi Okano; Minoru Oshima; Hironobu Suto; Yasuhisa Ando; Eisuke Asano; Hideki Kamada; Hideki Kobara; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2021-04-02       Impact factor: 2.549

7.  Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy.

Authors:  Chaobin He; Yize Mao; Jun Wang; Fangting Duan; Xiaojun Lin; Shengping Li
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

8.  Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy.

Authors:  Wenqin Wang; Wei Liu; Ning Zhang; Xiaodong He
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

9.  Ampullary Adenocarcinoma with Incidental Pancreatic Neuroendocrine Tumor: Report of an Extremely Rare Case and Review of Literature.

Authors:  Matteo Viti; Pietro Maria Lombardi; Mattia Marinelli; Monica Onorati; Corrado D'Urbano
Journal:  Cureus       Date:  2019-11-13

10.  Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

Authors:  Michael Feretis; Tengyao Wang; Satheesh Iype; Adam Duckworth; Rebecca Brais; Bristi Basu; Neville V Jamieson; Emmanuel Huguet; Anita Balakrishnan; Asif Jah; Raaj K Praseedom; Simon J Harper; Siong-Seng Liau
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.